文献速递骨质疏松与钙磷/甲状旁腺性腺与生殖内分泌

老年男性血浆睾酮与骨折发生率呈U型关联,而血浆雌二醇无关联

U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

分析3307名社区居住老年男性(平均76.8±3.5岁,中位随访10.6年),用质谱法测血浆睾酮、双氢睾酮和雌二醇,免疫法测性激素结合球蛋白和促黄体生成素,通过数据链接确定骨折。结果330例发生骨折(含144例髋部骨折);血浆睾酮与任何骨折和髋部骨折呈U型关联,双氢睾酮、雌二醇和促黄体生成素与骨折无关联,较高的性激素结合球蛋白与髋部骨折风险增加相关。

要点

  • 血浆睾酮与任何骨折和髋部骨折呈U型关联,中间四分位风险较低。
  • 双氢睾酮、雌二醇和促黄体生成素与骨折无关联。
  • 较高的性激素结合球蛋白与髋部骨折风险增加相关。

核心结论

  • 中间范围的血浆睾酮与任何骨折和髋部骨折发生率较低相关,较高的性激素结合球蛋白与髋部骨折风险增加相关;循环雄激素而非雌激素是激素对骨影响驱动骨折风险的生物标志物。

研究设计与样本

  • 分析3307名社区居住男性,年龄76.8±3.5岁,中位随访10.6年;用质谱法测血浆睾酮、双氢睾酮和雌二醇,免疫法测性激素结合球蛋白和促黄体生成素;通过数据链接确定骨折;进行Cox回归校正年龄、合并症和衰弱。

主要发现

  • 330名男性发生骨折,包括144例髋部骨折。
  • 血浆睾酮与任何骨折呈U型关联:Q2 vs Q1 完全校正HR=0.69,95%CI 0.51-0.94,P=.020;Q3 vs Q1 HR=0.59,95%CI 0.42-0.83,P=.002。
  • 血浆睾酮与髋部骨折呈U型关联:Q2 vs Q1 HR=0.60,95%CI 0.37-0.93,P=.043;Q3 vs Q1 HR=0.52,95%CI 0.31-0.88,P=.015。
  • 双氢睾酮、雌二醇和促黄体生成素与骨折无关联;较高的性激素结合球蛋白与髋部骨折相关:Q4 vs Q1 HR=1.76,95%CI 1.05-2.96,P=.033。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Whether androgens, distinct from estrogen, maintain bone health during male aging has implications for understanding osteoporosis. We assessed associations of different sex hormones with incidence of any bone fracture or hip fracture in older men. PARTICIPANTS AND METHODS: Analysis of 3307 community-dwelling men aged 76.8 ± 3.5 years, median follow-up period of 10.6 years. Plasma testosterone (T), dihydrotestosterone (DHT), and estradiol (E2) assayed by mass spectrometry, sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) using immunoassay. Incident fractures determined via data linkage. We analyzed probability of fracture and performed Cox regression adjusted for age, medical comorbidities, and frailty. RESULTS: Incident fractures occurred in 330 men, including 144 hip fractures. Probability plots suggested nonlinear relationships between hormones and risk of any fracture and hip fracture, with higher risk at lower and higher plasma T, lower E2, higher SHBG, and higher LH. In fully adjusted models, there was a U-shaped association of plasma T with incidence of any fracture (Quartile 2 [Q2] versus Q1: fully adjusted hazard ratio [HR] = 0.69, 95% confidence interval [CI] 0.51-0.94, P = .020; Q3: HR 0.59, 95% CI 0.42-0.83, P = .002) and hip fracture (Q2 versus Q1: HR 0.60, 95% CI 0.37-0.93, P = .043; Q3: HR 0.52, 95% CI 0.31-0.88, P = .015). DHT, E2, and LH were not associated with fracture. Higher SHBG was associated with hip fracture (Q4 versus Q1: HR 1.76, 95% CI 1.05-2.96, P = .033). CONCLUSIONS: Midrange plasma T was associated with lower incidence of any fracture and hip fracture, and higher SHBG with increased risk of hip fracture. Circulating androgen rather than estrogen represents a biomarker for hormone effects on bone driving fracture risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yeap BB, Alfonso H, Chubb SAP, et al. U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men. J Clin Endocrinol Metab. 2020. PMID: 32155267. doi:10.1210/clinem/dgaa115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。